
|Videos|August 10, 2021
Pharmacist Medication Insights: Octagam for Chronic Immune Thrombocytopenic Purpura
Author(s)Saro Arakelians, PharmD
Octagam 10% is indicated for the treatment of chronic immune thrombocytopenic purpura in adults and dermatomyositis (DM) in adults
Advertisement
Octagam 10% is an immune globulin intravenous (human) liquid preparation indicated for the treatment of:
- Chronic immune thrombocytopenic purpura (ITP) in adults
- Dermatomyositis (DM) in adults
Further, Octagam 10% is the first and only intravenous immunoglobulin to be indicated for the treatment of adult dermatomyositis.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
4
New Research Suggests Bempedoic Acid Outperforms Ezetimibe for Heart Health in Patients with Type 2 Diabetes
5





































































































































